These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 29580877

  • 1. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
    Clémençon B, Lüscher BP, Hediger MA.
    J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
    [Abstract] [Full Text] [Related]

  • 2. In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1.
    Pak YA, Long AJ, Annes WF, Witcher JW, Knadler MP, Ayan-Oshodi MA, Mitchell MI, Leese P, Hillgren KM.
    Drug Metab Dispos; 2017 Feb; 45(2):137-144. PubMed ID: 27895114
    [Abstract] [Full Text] [Related]

  • 3. Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice.
    Yang B, Smith DE.
    Drug Metab Dispos; 2013 Mar; 41(3):608-14. PubMed ID: 23264448
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells.
    Friedrichsen GM, Chen W, Begtrup M, Lee CP, Smith PL, Borchardt RT.
    Eur J Pharm Sci; 2002 Jul; 16(1-2):1-13. PubMed ID: 12113886
    [Abstract] [Full Text] [Related]

  • 5. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.
    Ganapathy ME, Huang W, Wang H, Ganapathy V, Leibach FH.
    Biochem Biophys Res Commun; 1998 May 19; 246(2):470-5. PubMed ID: 9610386
    [Abstract] [Full Text] [Related]

  • 6. The GFP thermal shift assay for screening ligand and lipid interactions to solute carrier transporters.
    Chatzikyriakidou Y, Ahn DH, Nji E, Drew D.
    Nat Protoc; 2021 Dec 19; 16(12):5357-5376. PubMed ID: 34707255
    [Abstract] [Full Text] [Related]

  • 7. Recent advances in understanding prodrug transport through the SLC15 family of proton-coupled transporters.
    Minhas GS, Newstead S.
    Biochem Soc Trans; 2020 Apr 29; 48(2):337-346. PubMed ID: 32219385
    [Abstract] [Full Text] [Related]

  • 8. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
    Schlessinger A, Zatorski N, Hutchinson K, Colas C.
    Trends Biochem Sci; 2023 Sep 29; 48(9):801-814. PubMed ID: 37355450
    [Abstract] [Full Text] [Related]

  • 9. Structural basis for prodrug recognition by the SLC15 family of proton-coupled peptide transporters.
    Minhas GS, Newstead S.
    Proc Natl Acad Sci U S A; 2019 Jan 15; 116(3):804-809. PubMed ID: 30602453
    [Abstract] [Full Text] [Related]

  • 10. Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir.
    Gourdon B, Chemin C, Moreau A, Arnauld T, Baumy P, Cisternino S, Péan JM, Declèves X.
    Int J Pharm; 2017 Aug 30; 529(1-2):357-370. PubMed ID: 28705621
    [Abstract] [Full Text] [Related]

  • 11. Structure of Prototypic Peptide Transporter DtpA from E. coli in Complex with Valganciclovir Provides Insights into Drug Binding of Human PepT1.
    Ural-Blimke Y, Flayhan A, Strauss J, Rantos V, Bartels K, Nielsen R, Pardon E, Steyaert J, Kosinski J, Quistgaard EM, Löw C.
    J Am Chem Soc; 2019 Feb 13; 141(6):2404-2412. PubMed ID: 30644743
    [Abstract] [Full Text] [Related]

  • 12. Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery.
    Foley DW, Pathak RB, Phillips TR, Wilson GL, Bailey PD, Pieri M, Senan A, Meredith D.
    Eur J Med Chem; 2018 Aug 05; 156():180-189. PubMed ID: 30006163
    [Abstract] [Full Text] [Related]

  • 13. Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter PepT1 targeting and oxytocin transport.
    Gourdon B, Chemin C, Moreau A, Arnauld T, Delbos JM, Péan JM, Declèves X.
    Eur J Pharm Biopharm; 2018 Aug 05; 129():122-133. PubMed ID: 29803721
    [Abstract] [Full Text] [Related]

  • 14. High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies.
    Raturi S, Li H, Chang YN, Scacioc A, Bohstedt T, Fernandez-Cid A, Evans A, Abrusci P, Balakrishnan A, Pascoa TC, He D, Chi G, Kaur Singh N, Ye M, Li A, Shrestha L, Wang D, Williams EP, Burgess-Brown NA, Dürr KL, Puetter V, Ingles-Prieto A, Sauer DB.
    J Vis Exp; 2023 Sep 29; (199):. PubMed ID: 37843272
    [Abstract] [Full Text] [Related]

  • 15. Several hPepT1-transported drugs are substrates of the Escherichia coli proton-coupled oligopeptide transporter YdgR.
    Prabhala BK, Aduri NG, Iqbal M, Rahman M, Gajhede M, Hansen PR, Mirza O.
    Res Microbiol; 2017 Jun 29; 168(5):443-449. PubMed ID: 28214542
    [Abstract] [Full Text] [Related]

  • 16. SLC Family Transporters.
    Liu X.
    Adv Exp Med Biol; 2019 Jun 29; 1141():101-202. PubMed ID: 31571165
    [Abstract] [Full Text] [Related]

  • 17. Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells.
    Irie M, Terada T, Sawada K, Saito H, Inui K.
    J Pharmacol Exp Ther; 2001 Aug 29; 298(2):711-7. PubMed ID: 11454935
    [Abstract] [Full Text] [Related]

  • 18. Impact of peptide transporter 1 on the intestinal absorption and pharmacokinetics of valacyclovir after oral dose escalation in wild-type and PepT1 knockout mice.
    Yang B, Hu Y, Smith DE.
    Drug Metab Dispos; 2013 Oct 29; 41(10):1867-74. PubMed ID: 23924683
    [Abstract] [Full Text] [Related]

  • 19. Recent developments in ligands and chemical probes targeting solute carrier transporters.
    Casiraghi A, Bensimon A, Superti-Furga G.
    Curr Opin Chem Biol; 2021 Jun 29; 62():53-63. PubMed ID: 33689964
    [Abstract] [Full Text] [Related]

  • 20. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir.
    Balimane PV, Tamai I, Guo A, Nakanishi T, Kitada H, Leibach FH, Tsuji A, Sinko PJ.
    Biochem Biophys Res Commun; 1998 Sep 18; 250(2):246-51. PubMed ID: 9753615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.